Implementación del sistema bethesda para informar citopatología de la tiroides en el Centro Oncológico SOLCA Loja

Abstract

Abstract: The system Bethesda (TBSRTC) to inform thyroid cytopathology, is presented following the organization of the National Cancer Institute, in a conference called "State of the science" in October 2007, with representatives in pathology and endocrinology in order to introduce a standardized terminology for the thyroid. cytopathology report, capable of providing useful, accurate, unambiguous information, without variation from one laboratory to another, avoiding confusion at the time of its interpretation, so the Bethesda system with 6 clearly defined categories and with an implicit risk of cancer, is considered the only international terminology to classify the results of fine needle aspiration (FNA), which is why it has not only been widely accepted throughout the world, but is also endorsed by the American Thyroid Association, becoming the system of standardized reference to report after confirming its effectiveness and feasibility in various meta-analyzes, in such a way that it can be understood in all countries, trying to provide better support to the doctor to make referrals to treatment.